The Affordable Care Act was implemented to change healthcare in the United States. In order to support that change, the government established the Center for Medicare and Medicaid Innovation (CMMI)-a sector of the government agency that aims to incentivize innovation among providers and payers.
The Affordable Care Act was implemented to change healthcare in the United States. In order to support that change, the government established the Center for Medicare and Medicaid Innovation (CMMI)—a sector of the government agency that aims to incentivize innovation among providers and payers.
States across the country have benefited from CMMI’s 10-year, $10 billion budget. In fact, it is the largest sum of funding ever devoted to healthcare transformation. The center intends to accelerate the development and testing of new payment and service delivery models at various healthcare organizations. The center’s supported innovation models are divided into 7 categories:
The group also encourages healthcare organizations and leaders to offer their own ideas about innovations. The center says it seeks input on innovative service delivery models, reimbursement models, and even technology.
“We look for ideas across the healthcare delivery continuum that achieve better care for patients, better health for our communities, and lower costs through improvement for our healthcare system,” the center said.
Still, not everyone is completely convinced that the group is fulfilling its purpose. “This is absolutely necessary” to try to change how care is bought and delivered, said Christopher Koller, president of the Milbank Memorial Fund, a nonprofit that works to improve medical decision making. “Is this the right way to do it? A whole bunch of experiments? Is the innovation center adequately resourced in an administrative way to do this? The jury is still out on this.”
CMMI programs focus on patient populations with expensive conditions including cancer, diabetes, and heart failure. Groups who opt into CMMI innovation programs must demonstrate quality improvements within 6 months of enrollment. Center officials maintain that the group has an important role in improving patients’ health and controlling the rising costs of healthcare throughout the country.
“We take the direction of Congress—that the goal was to test these models, to expand the successful ones, but also to terminate unsuccessful ones—very seriously,” said Patrick Conway, MD, who runs the center.
Around the Web
CMS is on a $10B Search for the Next Big Health Insurance Innovation — But Is It Going Anywhere? [MedCity News]
Innovation Models [CMS - CMMI]
Balancing Cost and Quality in Oncology: A Value-Based Care Perspective
January 30th 2025Travis Brewer, vice president of payer and public health strategy/relations at Texas Oncology, shared that value-based oncology care can achieve both cost efficiency and high-quality outcomes through integrated multidisciplinary teams, flexible payment models, and targeted treatment approaches.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Decisions and Precision in Value-Based Cancer Care
January 7th 2025An Institute for Value-Based Medicine regional event in Houston, Texas, covered inconsistencies with the integration of precision medicine in oncology practices, the evolution of treatment for multiple myeloma, and more.
Read More